JP2023058515A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023058515A5 JP2023058515A5 JP2023006843A JP2023006843A JP2023058515A5 JP 2023058515 A5 JP2023058515 A5 JP 2023058515A5 JP 2023006843 A JP2023006843 A JP 2023006843A JP 2023006843 A JP2023006843 A JP 2023006843A JP 2023058515 A5 JP2023058515 A5 JP 2023058515A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2018-0036190 | 2018-03-28 | ||
KR1020180036190A KR102340989B1 (ko) | 2018-03-28 | 2018-03-28 | 클라우딘 3의 ecl-2에 특이적으로 결합하는 항체, 이의 단편 및 이들의 용도 |
PCT/KR2019/003594 WO2019190206A1 (ko) | 2018-03-28 | 2019-03-27 | 클라우딘 3의 ecl-2에 특이적으로 결합하는 항체, 이의 단편 및 이들의 용도 |
JP2020552830A JP7311530B2 (ja) | 2018-03-28 | 2019-03-27 | クローディン3のecl-2に特異的に結合する抗体、その断片及びその使用 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020552830A Division JP7311530B2 (ja) | 2018-03-28 | 2019-03-27 | クローディン3のecl-2に特異的に結合する抗体、その断片及びその使用 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2023058515A JP2023058515A (ja) | 2023-04-25 |
JP2023058515A5 true JP2023058515A5 (ja) | 2023-09-15 |
Family
ID=68060609
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020552830A Active JP7311530B2 (ja) | 2018-03-28 | 2019-03-27 | クローディン3のecl-2に特異的に結合する抗体、その断片及びその使用 |
JP2023006843A Pending JP2023058515A (ja) | 2018-03-28 | 2023-01-19 | クローディン3のecl-2に特異的に結合する抗体、その断片及びその使用 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020552830A Active JP7311530B2 (ja) | 2018-03-28 | 2019-03-27 | クローディン3のecl-2に特異的に結合する抗体、その断片及びその使用 |
Country Status (11)
Country | Link |
---|---|
US (1) | US20210115134A1 (ja) |
EP (1) | EP3778638A4 (ja) |
JP (2) | JP7311530B2 (ja) |
KR (1) | KR102340989B1 (ja) |
CN (1) | CN112204053A (ja) |
AU (1) | AU2019243255B2 (ja) |
BR (1) | BR112020019553A2 (ja) |
CA (1) | CA3095139A1 (ja) |
MX (1) | MX2020010082A (ja) |
RU (1) | RU2768002C1 (ja) |
WO (1) | WO2019190206A1 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210037581A (ko) * | 2019-09-26 | 2021-04-06 | (재)록원바이오융합연구재단 | 항-클라우딘-3 키메라 항원 수용체 |
BR112023018987A2 (pt) * | 2021-03-19 | 2023-12-05 | Glaxosmithkline Ip Dev Ltd | Receptores de antígenos quiméricos direcionados à claudina-3 e métodos de tratamento do câncer |
CN114478802B (zh) * | 2022-01-28 | 2023-05-26 | 郑州大学 | 一种嵌合抗原受体及其应用 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
US5707644A (en) | 1989-11-04 | 1998-01-13 | Danbiosyst Uk Limited | Small particle compositions for intranasal drug delivery |
US5756353A (en) | 1991-12-17 | 1998-05-26 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol-and liposome-based delivery |
EP1790664A1 (en) * | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against claudin-18 for treatment of cancer |
AU2007332473B2 (en) * | 2006-12-14 | 2012-09-27 | Forerunner Pharma Research Co., Ltd. | Anti-Claudin-3 monoclonal antibody, and treatment and diagnosis of cancer using the same |
WO2009028663A1 (ja) * | 2007-08-30 | 2009-03-05 | Kyowa Hakko Kirin Co., Ltd. | 抗Claudin-3抗体 |
CN107090043B (zh) * | 2011-05-13 | 2021-12-07 | 加尼梅德药物公司 | 用于治疗表达密蛋白6之癌症的抗体 |
US9751941B2 (en) * | 2013-03-14 | 2017-09-05 | Abion Inc. | Antigen derived from extracellular domain of multi-transmembrane protein and uses thereof |
KR101782623B1 (ko) * | 2013-07-10 | 2017-09-28 | 서울대학교산학협력단 | 복합 막횡단 단백질의 세포막외 펩타이드 항원 및 그의 용도 |
MX2016005763A (es) * | 2013-11-06 | 2016-08-19 | Stemcentrx Inc | Anticuerpos anti-claudina novedosos y metodos de uso. |
CN104548130A (zh) * | 2014-09-16 | 2015-04-29 | 四川大学 | 一种干扰Claudin3 基因表达的靶向脂质体 |
SG11201708191XA (en) * | 2015-04-08 | 2017-11-29 | Novartis Ag | Cd20 therapies, cd22 therapies, and combination therapies with a cd19 chimeric antigen receptor (car) - expressing cell |
WO2016180468A1 (en) * | 2015-05-11 | 2016-11-17 | Biontech Cell & Gene Therapies Gmbh | Claudin-18.2-specific immunoreceptors and t cell epitopes |
KR20180036190A (ko) | 2016-09-30 | 2018-04-09 | 양진홍 | 키워드 기반의 장면 인식 방법 및 시스템 |
KR102055936B1 (ko) * | 2017-09-20 | 2019-12-16 | 에이비온 주식회사 | 클라우딘 3 및 4에 대한 단일클론항체 및 그의 용도 |
-
2018
- 2018-03-28 KR KR1020180036190A patent/KR102340989B1/ko active IP Right Grant
-
2019
- 2019-03-27 EP EP19778218.8A patent/EP3778638A4/en active Pending
- 2019-03-27 US US17/042,374 patent/US20210115134A1/en active Pending
- 2019-03-27 CA CA3095139A patent/CA3095139A1/en active Pending
- 2019-03-27 JP JP2020552830A patent/JP7311530B2/ja active Active
- 2019-03-27 MX MX2020010082A patent/MX2020010082A/es unknown
- 2019-03-27 BR BR112020019553-7A patent/BR112020019553A2/pt unknown
- 2019-03-27 AU AU2019243255A patent/AU2019243255B2/en active Active
- 2019-03-27 CN CN201980035930.1A patent/CN112204053A/zh active Pending
- 2019-03-27 RU RU2020133771A patent/RU2768002C1/ru active
- 2019-03-27 WO PCT/KR2019/003594 patent/WO2019190206A1/ko unknown
-
2023
- 2023-01-19 JP JP2023006843A patent/JP2023058515A/ja active Pending